Priser
Platform
Blog
Om os
Download
Paul Hartmann
Paul Hartmann
Xetra
0

Om

Paul Hartmann AG is a global healthcare company known for its comprehensive range of health products and solutions. Primarily focused on healthcare and associated services, its core purpose is to improve medical care and enhance the well-being of patients worldwide. Based in Germany, the company excels in the manufacture and distribution of products such as wound management solutions, incontinence and personal healthcare items, and surgical supplies. Paul Hartmann AG holds a significant presence in both consumer and professional healthcare sectors, impacting industries ranging from hospital systems to home healthcare services. Within the financial market, Paul Hartmann AG plays a critical role as a provider of essential health products and technologies that address the increasingly complex demands of modern healthcare systems. By maintaining a focus on innovation and quality, the company contributes to the efficiency, reliability, and effectiveness of medical treatment protocols, ensuring better patient outcomes and supporting the global healthcare infrastructure.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PAUL HARTMANN MED ENDAVU: Køb Paul Hartmann ($PHH2) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Paul Hartmann, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerPHH2
Land
Tyskland
Antal medarbejdere10.066
Hjemmesidehartmann.info
SektorSundhed
IndustriMedicinske instrumenter og forsyninger

Udbytter

8EUR
'21
8EUR
'22
8EUR
'23
8EUR
'24
8EUR
'25
8EUR
'26
Ex-udbytte-dato30. apr. 2026
Udbytteafkast3,94%